annual cash & cash equivalents:
$71.62M+$4.17M(+6.19%)Summary
- As of today (September 16, 2025), XERS annual cash & cash equivalents is $71.62 million, with the most recent change of +$4.17 million (+6.19%) on December 31, 2024.
- During the last 3 years, XERS annual cash & cash equivalents has risen by +$4.35 million (+6.47%).
- XERS annual cash & cash equivalents is now -41.28% below its all-time high of $121.97 million, reached on December 31, 2022.
Performance
XERS Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$59.28M+$845.00K(+1.45%)Summary
- As of today (September 16, 2025), XERS quarterly cash & cash equivalents is $59.28 million, with the most recent change of +$845.00 thousand (+1.45%) on June 30, 2025.
- Over the past year, XERS quarterly cash & cash equivalents has dropped by -$18.28 million (-23.57%).
- XERS quarterly cash & cash equivalents is now -58.83% below its all-time high of $144.00 million, reached on June 30, 2020.
Performance
XERS quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
XERS Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +6.2% | -23.6% |
| 3 y3 years | +6.5% | -46.9% |
| 5 y5 years | +266.9% | -58.8% |
XERS Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -41.3% | +6.5% | -51.4% | +1.4% |
| 5 y | 5-year | -41.3% | +266.9% | -58.8% | +1.4% |
| alltime | all time | -41.3% | +266.9% | -58.8% | +41.0% |
XERS Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $59.28M(+1.4%) |
| Mar 2025 | - | $58.44M(-18.4%) |
| Dec 2024 | $71.62M(+6.2%) | $71.62M(+3.2%) |
| Sep 2024 | - | $69.40M(-10.5%) |
| Jun 2024 | - | $77.57M(-11.2%) |
| Mar 2024 | - | $87.35M(+20.6%) |
| Dec 2023 | $67.45M(-44.7%) | $72.45M(+9.8%) |
| Sep 2023 | - | $65.97M(-18.2%) |
| Jun 2023 | - | $80.67M(-15.2%) |
| Mar 2023 | - | $95.10M(-22.0%) |
| Dec 2022 | $121.97M(+81.3%) | $121.97M(+30.5%) |
| Sep 2022 | - | $93.43M(-16.2%) |
| Jun 2022 | - | $111.55M(-15.6%) |
| Mar 2022 | - | $132.15M(+29.0%) |
| Dec 2021 | $67.27M | $102.43M(+10.2%) |
| Sep 2021 | - | $92.98M(-19.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2021 | - | $115.98M(-14.7%) |
| Mar 2021 | - | $135.89M(+1.6%) |
| Dec 2020 | $37.60M(+92.6%) | $133.79M(-5.6%) |
| Sep 2020 | - | $141.74M(-1.6%) |
| Jun 2020 | - | $144.00M(+48.5%) |
| Mar 2020 | - | $96.94M(+28.3%) |
| Dec 2019 | $19.52M(-57.3%) | $75.55M(+34.5%) |
| Sep 2019 | - | $56.16M(-15.8%) |
| Jun 2019 | - | $66.67M(+7.6%) |
| Mar 2019 | - | $61.98M(+35.6%) |
| Dec 2018 | $45.72M(+8.7%) | $45.72M(-39.6%) |
| Sep 2018 | - | $75.75M(-43.7%) |
| Jun 2018 | - | $134.53M(+131.5%) |
| Mar 2018 | - | $58.11M(+38.2%) |
| Dec 2017 | $42.05M(+30.3%) | $42.05M |
| Dec 2016 | $32.27M | - |
FAQ
- What is Xeris Biopharma Holdings, Inc. annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Xeris Biopharma Holdings, Inc.?
- What is Xeris Biopharma Holdings, Inc. annual cash & cash equivalents year-on-year change?
- What is Xeris Biopharma Holdings, Inc. quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Xeris Biopharma Holdings, Inc.?
- What is Xeris Biopharma Holdings, Inc. quarterly cash & cash equivalents year-on-year change?
What is Xeris Biopharma Holdings, Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of XERS is $71.62M
What is the all time high annual cash & cash equivalents for Xeris Biopharma Holdings, Inc.?
Xeris Biopharma Holdings, Inc. all-time high annual cash & cash equivalents is $121.97M
What is Xeris Biopharma Holdings, Inc. annual cash & cash equivalents year-on-year change?
Over the past year, XERS annual cash & cash equivalents has changed by +$4.17M (+6.19%)
What is Xeris Biopharma Holdings, Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of XERS is $59.28M
What is the all time high quarterly cash & cash equivalents for Xeris Biopharma Holdings, Inc.?
Xeris Biopharma Holdings, Inc. all-time high quarterly cash & cash equivalents is $144.00M
What is Xeris Biopharma Holdings, Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, XERS quarterly cash & cash equivalents has changed by -$18.28M (-23.57%)